Table 3 Prescribed non-steroidal anti-inflammatory drugs and centrally acting agents. (*) means that the drug was discontinued at least 24 hrs before the study. Plasma half-life of each compound is also indicated.
From: Norepinephrine-evoked pain in fibromyalgia. A randomized pilot study ISCRTN70707830
Fibromyalgia | Rheumatoid Arthritis | ||||
|---|---|---|---|---|---|
Drug | Number of patients | Plasma half-life (hours) | Drug | Number of patients | Plasma half-life (hours) |
clonazepam | 6 | 20–60 | acetaminophen* | 4 | 4–6 |
acetaminophen* | 5 | 4–6 | celecoxib* | 3 | 10–12 |
mianserin | 2 | 21–61 | diclofenac* | 3 | 3–7 |
alprazolam | 2 | 12–15 | piroxicam* | 2 | 34–50 |
bromazepam | 1 | 20 | clonazepam | 1 | 20–60 |
triazolam | 1 | 1.5–5.5 | alprazolam | 1 | 12–15 |
piroxicam* | 1 | 34–50 | indomethacin* | 1 | 4–5 |
celecoxib* | 1 | 10–12 | aspirin* | 1 | 2–3 |
ketoprofen* | 1 | 1.5–4 | rofecoxib* | 1 | 17 |
fluoxetine | 1 | 96–144 | ibuprofen* | 1 | 2–3 |
gabapentin* | 1 | 5–9 | gabapentin* | 1 | 5–9 |